Joinn Laboratories' (HKG:6127, SHA:603127) attributable profit fell 58% year over year to 99.4 million yuan in the third quarter, according to a Wednesday filing with the Hong Kong Exchange.
Earnings per share at the pharmacology and toxicology research company decreased 59% year over year to 0.13 yuan.
Operating income declined 16% year over year to 485.8 million yuan.
Shares fell 1% during Friday's trading.